• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

P57 免疫组化标志物在尼日利亚西南部一家三级医疗机构葡萄胎病例中的诊断工具。

P57 immunohistochemical marker as a diagnostic tool for cases of hydatidiform moles in a tertiary health facility in Southwestern Nigeria.

机构信息

Department of Pathology, University College Hospital, Ibadan, Oyo State, Nigeria.

Department of Pathology, University College Hospital; Department of Pathology, College of Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria.

出版信息

Niger Postgrad Med J. 2020 Oct-Dec;27(4):331-335. doi: 10.4103/npmj.npmj_231_20.

DOI:10.4103/npmj.npmj_231_20
PMID:33154286
Abstract

BACKGROUND

Hydatidiform mole (HM) is the most common gestational trophoblastic disease. P57 has been reported to be helpful in differentiating between partial and complete HMs.

OBJECTIVES

The study aims to evaluate the P57 immunohistochemical (IHC) marker as a useful ancillary investigation to differentiate complete hydatidiform mole (CHM) from partial hydatidiform mole (PHM).

MATERIALS AND METHODS

A retrospective study of all histologically diagnosed HM cases over a 20 year period was undertaken. Clinicopathological parameters were extracted from the surgical day book and medical record archives. Archival haematoxylin- and eosin-stained slides and formalin-fixed paraffin-embedded tissue blocks of all cases of HM diagnosed within the study period were retrieved and reviewed. Cases of HM were reclassified using the P57 IHC marker. The data obtained were analysed using the SPSS version 23.

RESULTS

One hundred cases of HMs were studied. CHM accounted for 68%, while PHM accounted for the remaining 32%. The incidence of HM was 2.98 cases per 1000 deliveries. The ratio of CHM to PHM was found to be 2.1:1. Seventy-two per cent of the cases were diagnosed in the first trimester, while the remaining 28% were diagnosed in the second trimester of pregnancy. Based on the P57 IHC staining pattern, HM cases were finally reclassified into 68 cases of CHM and 32 cases of PHM. The age range for all the HM cases was 18-50 years with the majority of the cases seen in the third and fourth decades of life.

CONCLUSION

P57 could be useful as an ancillary investigation in confirming the diagnosis of CHM and differentiating it from PHM, particularly in difficult and challenging cases.

摘要

背景

葡萄胎(HM)是最常见的妊娠滋养细胞疾病。已有报道称 P57 有助于区分部分性和完全性 HM。

目的

本研究旨在评估 P57 免疫组织化学(IHC)标志物作为辅助诊断完全性葡萄胎(CHM)与部分性葡萄胎(PHM)的有用方法。

材料与方法

对 20 年来所有经组织学诊断的 HM 病例进行回顾性研究。从手术日簿和病历档案中提取临床病理参数。检索并回顾研究期间所有 HM 病例的苏木精-伊红染色切片和福尔马林固定石蜡包埋组织块。使用 P57 IHC 标志物对 HM 病例进行重新分类。使用 SPSS 版本 23 分析获得的数据。

结果

研究了 100 例 HM。CHM 占 68%,PHM 占 32%。HM 的发病率为每 1000 例分娩 2.98 例。CHM 与 PHM 的比例为 2.1:1。72%的病例在孕早期诊断,其余 28%在孕中期诊断。根据 P57 IHC 染色模式,HM 病例最终重新分类为 68 例 CHM 和 32 例 PHM。所有 HM 病例的年龄范围为 18-50 岁,大多数病例见于 30-40 岁。

结论

P57 可作为辅助诊断 CHM 的方法,有助于区分 CHM 和 PHM,特别是在疑难和挑战性病例中。

相似文献

1
P57 immunohistochemical marker as a diagnostic tool for cases of hydatidiform moles in a tertiary health facility in Southwestern Nigeria.P57 免疫组化标志物在尼日利亚西南部一家三级医疗机构葡萄胎病例中的诊断工具。
Niger Postgrad Med J. 2020 Oct-Dec;27(4):331-335. doi: 10.4103/npmj.npmj_231_20.
2
Determination of morphologic and immunohistochemical stain (p57 ) discrepancy of complete and partial hydatidiform mole by using microsatellite genotyping.应用微卫星基因分型检测完全性和部分性葡萄胎的形态学和免疫组织化学染色(p57)差异。
Taiwan J Obstet Gynecol. 2020 Jul;59(4):570-574. doi: 10.1016/j.tjog.2020.05.017.
3
Challenges in the Routine Praxis Diagnosis of Hydatidiform Mole: a Tertiary Health Center Experience.葡萄胎常规实践诊断中的挑战:一家三级医疗中心的经验
Med Arch. 2017 Aug;71(4):256-260. doi: 10.5455/medarh.2017.71.256-260.
4
[Roles of p57KIP2 immunohistochemistry and flow cytometry in diagnosis of molar pregnancy].[P57KIP2免疫组化及流式细胞术在葡萄胎诊断中的作用]
Zhonghua Bing Li Xue Za Zhi. 2009 Sep;38(9):580-4.
5
The usefulness of p57(KIP2) immunohistochemical staining and genotyping test in the diagnosis of the hydatidiform mole.p57(KIP2) 免疫组化染色和基因分型检测在葡萄胎诊断中的应用。
Pathol Res Pract. 2011 Aug 15;207(8):498-504. doi: 10.1016/j.prp.2011.06.004. Epub 2011 Jul 20.
6
Recurrent Androgenetic Complete Hydatidiform Moles with p57-Positive in a Chinese Family.一家系中 p57 阳性复发性完全性葡萄胎
Reprod Sci. 2022 Jun;29(6):1749-1755. doi: 10.1007/s43032-021-00747-4. Epub 2021 Oct 4.
7
Accuracy of p57 compared with genotyping for the diagnosis of complete hydatidiform mole: protocol for a systematic review and meta-analysis.与基因分型相比,p57在完全性葡萄胎诊断中的准确性:系统评价与荟萃分析方案
Syst Rev. 2016 Oct 4;5(1):169. doi: 10.1186/s13643-016-0349-7.
8
Complementary role of p57kip2 immunostaining in diagnosing hydatidiform mole subtypes.p57kip2 免疫染色在诊断葡萄胎亚型中的互补作用。
Horm Mol Biol Clin Investig. 2021 May 21;42(3):311-316. doi: 10.1515/hmbci-2020-0086.
9
A clinico-pathological study of complete and partial hydatidiform moles in a Nigerian population.尼日利亚人群中完全性和部分性葡萄胎的临床病理研究。
J Obstet Gynaecol. 2002 Jul;22(4):423-5. doi: 10.1080/01443610220141425.
10
Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach.使用p57免疫组织化学和分子基因分型对葡萄胎进行诊断和亚分类:在常规和会诊实践环境中的验证及前瞻性分析,并开发算法方法
Am J Surg Pathol. 2009 Jun;33(6):805-17. doi: 10.1097/PAS.0b013e318191f309.